Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Eskişehir
Clinical trial register · Turkey

Clinical Trials in Eskişehir, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Istanbul 1988 Ankara 1440 Izmir 568 Adana 377 Antalya 261
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Eskisehir Osmangazi University9 Eli Lilly and Company6 Merck Sharp & Dohme LLC6 AstraZeneca5 Novo Nordisk A/S4
Site location
Istanbul1988 Ankara1440 Izmir568 Adana377 Antalya261
All 318 locations
Target enrolment
to

Trials with a site in Eskişehir

68 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Not yet open
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Mersin, Dinar, Eskişehir, Istanbul
2027-11-23
Not yet open
Middle East North Africa Stroke and Interventional Neurotherapies Organization
Phase 3
280
Eskişehir, Istanbul
2027-07
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Istanbul, Kayseri, Adana, Adapazarı/Turkiye, Afyonkarahisar, Ankara, Çanakkale/Türkiye, Eskişehir
2026-10-26
Not yet open
Sakarya University
Not applicable
40
Eskişehir
2026-09-01
Not yet open
Internal Jugular Vein Respiratory Variability as a Marker of Disease Severity in Infant Bronchiolitis
NCT07778225Acute Bronchiolitis, Viral Bronchiolitis, Respiratory Syncytial Virus Infections
Eskisehir Osmangazi University
Observational
120
Eskişehir
2026-09-01
Recruiting
Triage Performance and Physiological Predictors of Serious Illness in Febrile Children in the Pediatric Emergency Department
NCT07739004Fever, Triage, Pediatric Emergency Medicine, Serious Bacterial Infection
TC Erciyes University
Observational
3,000
Kayseri, Adana, Antalya, Eskişehir, Istanbul, Izmir, Manisa, Tokat Province
2026-07-28
Active, closed
Effect of a Nutrition Education Intervention on Ultra-Processed Food Awareness and Consumption Among University Students
NCT07761559Ultra-Processed Food Consumption, Nutrition Knowledge, Ultra-processed Food, Food Insecurity
BENGİSU KARAGÖZ
Not applicable
74
Eskişehir
2026-07-13
Not yet open
Middle East North Africa Stroke and Interventional Neurotherapies Organization
Not applicable
440
Eskişehir, Istanbul
2026-07
Recruiting
The Effect of Intravenous Dexketoprofen on the Severity and Incidence of Rebound Pain
NCT07642674Postoperative Pain, Pain Management, Rebound Pain, Interscalene Block
Eskisehir Osmangazi University
Not applicable
66
Eskişehir
2026-06-11
Recruiting
AI-Generated Personalized Story Book to Improve Patient Behaviour
NCT07778134Dental Anxiety in Children, Behavior Management, Pediatric Dental Anxiety
Eskisehir Osmangazi University
Not applicable
69
Eskişehir
2026-06-08
Recruiting
Novartis Pharmaceuticals
Phase 3
5,700
Izmir, Ankara, Istanbul, Eskişehir, Samsun, Mersin
2026-05-11
Active, closed
Individualized Nursing Care and Frailty Outcomes in Cardiac Surgery
NCT07471945Frail Patient, Cardiac Surgical Procedures (Postoperative Population), Patient-centered Care, Clinical Outcomes
SELDA MERT
Not applicable
75
Eskişehir
2026-03-01
Recruiting
Lower-Limb Muscle Mass and Cardiovascular and Muscular Performance in Males and Females
NCT07440615Physical Performance, Leg Muscle Mass, Muscle Strength, Aerobic Capacity
Uludag University
Not applicable
235
Eskişehir
2026-02-20
Recruiting
EFFECT OF NITI SYSTEMS AND XP-ENDO FINISHER ON POSTOPERATIVE PAIN
NCT07642596Postoperative Pain After Endodontic Treatment
BUSRA OZTURK
Not applicable
80
Eskişehir
2026-02-13
Recruiting
Eskişehir Osmangazi University Medicine Faculty Hospital
Observational
54
Eskişehir
2026-02-04
Recruiting
Insmed Incorporated
Phase 3
344
Adana, Ankara, Bursa, Eskişehir, Kayseri, Kocaeli, Trabzon
2026-01-07
Active, closed
Trakya University
Not applicable
164
Eskişehir
2026-01-06
Not yet open
Semanur Bilgiç
Not applicable
39
Eskişehir
2026-01-01
Active, closed
Eskisehir Osmangazi University
Not applicable
180
Eskişehir
2026-01-01
Recruiting
Evaluating the LGG of on Acute Infectious Diarrhea in Children
NCT07342101Acute Infectious Diarrhoea in Children
Eskisehir Osmangazi University
Not applicable
480
Eskişehir, Istanbul
2026-01-01
Not yet open
Escitalopram Plasma Concentrations in Premenopausal and Postmenopausal Women
NCT07259525Therapeutic Drug Monitoring (TDM), Menopause, Depression - Major Depressive Disorder, General Anxiety Disorder
Eskisehir Osmangazi University
Observational
94
Eskişehir
2026-01
Recruiting
Eli Lilly and Company
Phase 3
7,140
Adana, Afyonkarahisar, Ankara, Antalya, Çanakkale, Çorum, Eskişehir, Istanbul
2025-12-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
996
Sıhhiye, Ankara, Eskişehir, Istanbul, Kayseri, Malatya
2025-11-11
Recruiting
Eli Lilly and Company
Phase 2
252
Adana, Ankara, Antalya, Eskişehir, Hatay, İzmit, Malatya, Mersin
2025-11-10
Not yet open
Suleyman Demirel University
Not applicable
60
Eskişehir
2025-11
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Eskişehir, Istanbul, Izmir, Kocaeli, Konya, Muratpaşa, Sivas
2025-09-22
Recruiting
Evaluating Sexual Functioning in Trans Men During the Gender Affirmation Process: A Mixed Methods Study
NCT07131267Sexual Functioning, Transgender Men, Gender Affirmation Surgery
Eskisehir Osmangazi University
Observational
52
Eskişehir
2025-08-05
Recruiting
Eli Lilly and Company
Phase 3
290
Ankara, Bursa, Eskişehir, Hatay, Istanbul, Izmir, İzmit, Mersin
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
350
Ankara, Antalya, Bursa, Eskişehir, Hatay, Istanbul, Izmir, İzmit
2025-06-26
Recruiting
Gender Differences in Depression Severity, Gender-Sensitive Symptoms, Resilience, and Stigma in Major Depressive Disorder
NCT07474363Major Depressive Disorder (MDD), Gender Differences, Resilience, Psychological, Self Stigma
Eskisehir Osmangazi University
Observational
90
Eskişehir
2025-06-01
Active, closed
AstraZeneca
Phase 3
3,103
Adana, Afyonkarahisar, Ankara, Eskişehir, Izmir, Kocaeli, Odunpazari, Yenimahalle
2025-05-28
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Adana, Erzurum, Eskişehir, Gaziantep, Istanbul, Kütahya, Malatya, Mersin
2025-05-20
Recruiting
AstraZeneca
Phase 3
11,300
Adana, Afyonkarahisar, Ankara, Antalya, Eskişehir, Istanbul, Izmir, Kahramanmaraş
2025-03-14
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Atakum, Ankara, Eskişehir, Istanbul, Izmir
2024-09-26
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Bornova, Ankara, Eskişehir, Kayseri, Kocaeli
2024-08-05
Active, closed
PVP-Guided Decongestive Therapy in HF 2
NCT06495892Heart Failure, Congestion, Congestive Heart Failure
Başakşehir Çam & Sakura City Hospital
Phase 4
650
Ankara, Antalya, Edirne, Erzurum, Eskişehir, Istanbul, Izmir, Kahramanmaraş
2024-07-01
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Ankara, Istanbul, Eskişehir, Afyonkarahisar, Antalya, Bursa, Edirne, Kayseri
2024-06-25
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Adana, Afyonkarahisar, Ankara, Elâzığ, Erzurum, Eskişehir, Gaziantep, Istanbul
2024-06-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Bornova, Ankara, Antalya, Eskişehir, Istanbul, Kocaeli
2024-06-05
Recruiting
The Effect of Video-Based Education on Colonoscopy Preparation
NCT07229066Bowel Preparation Quality, Colonoscopy, Patient Education
Eskisehir Osmangazi University
Not applicable
246
Eskişehir
2024-06-01
Active, closed
Eli Lilly and Company
Phase 3
10,000
Afyonkarahisar, Ankara, Antalya, Bornova, Çorum, Edirne, Eskişehir, Gaziantep
2024-04-30
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
DrugTeriflunomide
Sanofi
Phase 3
2,500
Ankara, Eskişehir, Istanbul, Izmir, Kocaeli, Konya, Kütahya, Mersin
2024-04-16
Recruiting
AstraZeneca
Phase 3
3,850
Adana, Ankara, Antalya, Bursa, Center, Dinar, Eskişehir, Istanbul
2024-04-12
Active, closed
Novo Nordisk A/S
Phase 3
673
Eskişehir, Adana, Afyonkarahisar, Ankara, Bursa, Edirne, Istanbul, Kayseri
2024-04-01
Active, closed
Cynata Therapeutics Limited
Phase 2
60
Eskişehir, Istanbul, Izmir, Malatya, Yenimahalle
2024-03-04
Active, closed
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
NCT06183931Transthyretin Amyloid Cardiomyopathy
DrugCliramitug
Alexion Pharmaceuticals, Inc.
Phase 3
1,181
Ankara, Dinar, Eskişehir, Istanbul, Mersin
2024-01-11
Active, closed
Sanofi
Phase 3
943
Ankara, Bursa, Eskişehir, Istanbul, Izmir, İzmit, Kayseri, Konya
2023-12-27
Recruiting
AstraZeneca
Phase 3
1,145
Ankara, Antalya, Cordaleo, Eskişehir, Istanbul, Yenimahalle
2023-12-14
Active, closed
Sanofi
Phase 3
1,655
Ankara, Bursa, Eskişehir, Istanbul, Izmir, İzmit, Kayseri, Konya
2023-12-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Istanbul- Fatih, Ankara, Antalya, Edirne, Eskişehir, Istanbul, Kocaeli
2023-10-25
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
500
Atakum, Eskişehir, Istanbul, Izmir
2023-08-28
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Atakum, Ankara, Eskişehir, Istanbul, Izmir
2023-07-11
Recruiting
H. Lundbeck A/S
Phase 3
315
Eskişehir, Istanbul, Izmir, Mersin
2023-06-08
Active, closed
Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study
NCT05639569Aneurysm Thoracic, Dissection of Thoracic Aorta
Lifetech Scientific (Shenzhen) Co., Ltd.
Observational
147
Ankara, Erzurum, Eskişehir, Gaziantep, Izmir
2023-05-03
Active, closed
Merck Sharp & Dohme LLC
Phase 2
129
Ankara, Eskişehir, Istanbul
2023-03-16
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Izmir, Ankara, Istanbul, Denizli, Kayseri, Muğla, Eskişehir, Gaziantep
2023-03-09
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Ankara, Istanbul, Eskişehir, Bursa, Adana, Afyonkarahisar, Edirne, Izmir
2023-03-01
Recruiting
Occlutech International AB
Observational
50
Izmir, Eskişehir, Diyarbakır, Gaziantep
2022-03-03
Recruiting
Occlutech International AB
Observational
255
Aydin, Eskişehir, Adana, Diyarbakır
2021-12-20
Recruiting
H. Lundbeck A/S
Phase 3
600
Bayraklı, Eskişehir, Mersin
2021-12-01
Recruiting
H. Lundbeck A/S
Phase 3
285
Bayraklı, Eskişehir, Fatih/Istanbul, Mersin
2021-06-30
Active, closed
Sanofi
Phase 2
129
Eskişehir, Istanbul, İzmit, Mersin
2021-06-07
Active, closed
Regeneron Pharmaceuticals
Observational
100
Adana, Ankara, Eskişehir
2021-02-05
Active, closed
AstraZeneca
Phase 3
1,012
Ankara, Antalya, Eskişehir, Istanbul, Izmir, Kayseri
2020-07-13
Active, closed
Eli Lilly and Company
Phase 3
996
Ankara, Antalya, Bursa, Edirne, Eskişehir, Antakya, Istanbul, Istanbul- Fatih
2020-06-22
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Eskişehir, Adana, Mersin, Ankara, Bursa, Istanbul, Izmir
2019-09-23
Active, closed
Occlutech International AB
Observational
50
Eskişehir, Gaziantep, Izmir, Kocaeli
2019-07-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Ankara, Eskişehir, Istanbul, Izmir, Konya
2018-12-24
Rows per page Showing 1–68 of 68
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/eski-ehir

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 68 of those studies with a site in Eskişehir.

How many clinical trials are recruiting in Eskişehir?

31 of the 68 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 9 have not yet opened recruitment, 27 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Eskişehir), 68 studies
PhaseStudiesRecruitingShare
Phase 3381855.9%
Not applicable14620.6%
Observational11616.2%
Phase 2415.9%
Phase 4101.5%

Most active sponsors

Lead sponsors with the most studies (Eskişehir)
Lead sponsorStudiesRecruiting
Eskisehir Osmangazi University96
Eli Lilly and Company64
Merck Sharp & Dohme LLC61
AstraZeneca53
Novo Nordisk A/S40
Sanofi40
H. Lundbeck A/S33
Karuna Therapeutics, Inc., a Bristol Myers Squibb company33
Occlutech International AB32
Alexion Pharmaceuticals, Inc.20
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.